CT
CytomX Therapeutics Inc
🇺🇸XNAS.CTMXUnited StatesHealthcare
$2.69USDdown -0.01 (-0.37%)ClosedDelayed5:19 AM
Price$2.69-0.01 (-0.37%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US23284F1057
- CUSIP
- 23284F105
Company
- Employees
- 69
- Headquarters
- South San Francisco, United States
- Website
- https://www.cytomx.com
- CEO
- Dr. Sean A. McCarthy DPHIL
Market
- Shares outstanding
- 217.9M
- Market cap
- $586.15M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $586.15M
- EPS LTM
- -$0.37calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -7.36calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0.36%
Fundamentals (LTM)
- Revenue
- $18.3M-87.03%down year on year
- Net income
- -$79.65M-266%down year on year
- Gross margin
- 95.84%-3.64%down year on year
- Free cash flow
- -$82.48M-6.18%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.